Evidence map›Paper›PMID 27775695›Full record

Trial reportBone marrow transplantation2017

Peripheral blood stem cell mobilization in multiple myeloma comparison of two consecutive regimens in a limited resources country.

N Ben Abdejlil, D Belloumi, M Mâammar, R El Fatimi, L Torjman, A Lakhal, F Jenhani, S Hmida, T Ben Othman, S Ladeb

Abstract readClinical TrialComparative Study
PubMed Publisher
In one paragraph

Trial report in Bone marrow transplantation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

N Ben AbdejlilCentre National de Greffe de Moelle Osseuse de Tunis, Tunis, Tunisia.
D BelloumiCentre National de Greffe de Moelle Osseuse de Tunis, Tunis, Tunisia.
M MâammarCentre National de Transfusion Sanguine, Tunis, Tunisia.
R El FatimiCentre National de Greffe de Moelle Osseuse de Tunis, Tunis, Tunisia.
L TorjmanCentre National de Greffe de Moelle Osseuse de Tunis, Tunis, Tunisia.
A LakhalCentre National de Greffe de Moelle Osseuse de Tunis, Tunis, Tunisia.
F JenhaniCentre National de Transfusion Sanguine, Tunis, Tunisia.
S HmidaCentre National de Transfusion Sanguine, Tunis, Tunisia.
T Ben OthmanCentre National de Greffe de Moelle Osseuse de Tunis, Tunis, Tunisia.
S LadebCentre National de Greffe de Moelle Osseuse de Tunis, Tunis, Tunisia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study compared retrospectively the effectiveness, toxicity and hematopoietic recovery after autologous peripheral blood stem cell transplantation (ASCT) of two consecutive peripheral blood stem cell mobilization regimens in newly diagnosed MM patients. Patients in group 1 (n=178) were treated with 4 g/m

Indexed as

AdultAgedAllograftsCyclophosphamideFemaleGranulocyte Colony-Stimulating FactorHematopoietic Stem Cell MobilizationHumansMaleMiddle AgedMultiple MyelomaPeripheral Blood Stem Cell TransplantationCyclophosphamideGranulocyte Colony-Stimulating Factor

Identifiers

PMID27775695

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.